PUBLIC CONTRACT · 2024
Aquisição de produtos do aq 2023/492
- Contract value
- €97,150.00
- Signed on
- 23 April 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10908906PUBLISHED SUBJECT
TIGECICLINA 50 MG PÓ SOL INJ FR IV ; VALGANCICLOVIR 450 MG COMP; AMOXICILINA 125 MG/5 ML + ÁCIDO CLAVULÂNICO 31.25 MG/5 ML PÓ SUSP ORAL FR 120 ML; GANCICLOVIR 500 MG PÓ SOL INJ FR IV
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Generis Farmacêutica, S.A. · Tax ID 508107997
Values and timeline
- Contract price
- €97,150.00
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 September 2024
- Award date
- 22 April 2024
- Signing date
- 23 April 2024
- Performance period
- 253 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 492/2023 - Concurso público internacional para formação do acordo quadro de medicamentos anti-infeciosos na área da saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7056732
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.